OZEM vs. BBC ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Virtus LifeSci Biotech Clinical Trials ETF (BBC)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.41
Average Daily Volume
38,199
14
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Grade (RS Rating)
Last Trade
$25.96
Average Daily Volume
1,790
101
Performance
Period | OZEM | BBC |
---|---|---|
30 Days | -10.50% | -12.44% |
60 Days | -10.19% | -10.35% |
90 Days | -10.75% | -3.70% |
12 Months | 39.98% |
OZEM Underweight 98 Positions Relative to BBC
Symbol | Grade | Weight | |
---|---|---|---|
LBPH | A | -2.59% | |
SMMT | D | -1.96% | |
WVE | C | -1.83% | |
EWTX | C | -1.52% | |
APLT | B | -1.43% | |
BLTE | B | -1.43% | |
CNTA | B | -1.4% | |
ACLX | C | -1.36% | |
VRDN | D | -1.33% | |
IRON | B | -1.32% | |
RVMD | B | -1.2% | |
NRIX | C | -1.19% | |
SAVA | D | -1.17% | |
VERA | C | -1.07% | |
ERAS | C | -1.06% | |
PTGX | D | -1.04% | |
KYMR | D | -1.04% | |
IGMS | F | -1.03% | |
PCVX | D | -1.02% | |
QURE | D | -1.02% | |
CRNX | B | -1.01% | |
ABUS | D | -1.0% | |
JANX | C | -1.0% | |
AKRO | C | -0.99% | |
REPL | C | -0.99% | |
KROS | D | -0.99% | |
DNLI | D | -0.98% | |
PHVS | D | -0.97% | |
ORIC | F | -0.96% | |
ELVN | C | -0.96% | |
NUVL | D | -0.95% | |
XNCR | B | -0.94% | |
XENE | D | -0.91% | |
RNA | C | -0.91% | |
PLRX | D | -0.9% | |
ANNX | F | -0.88% | |
IMVT | F | -0.87% | |
COGT | D | -0.86% | |
ARQT | B | -0.86% | |
BEAM | D | -0.83% | |
CGON | F | -0.82% | |
CYTK | D | -0.82% | |
RCUS | F | -0.8% | |
BCYC | F | -0.78% | |
MLYS | F | -0.78% | |
ALLO | F | -0.77% | |
NUVB | C | -0.76% | |
ARVN | F | -0.74% | |
ETNB | D | -0.74% | |
VERV | D | -0.74% | |
DYN | D | -0.73% | |
ALEC | F | -0.71% | |
CELC | F | -0.71% | |
MRUS | F | -0.7% | |
ABCL | D | -0.69% | |
ANAB | F | -0.68% | |
VIR | F | -0.67% | |
TYRA | F | -0.67% | |
MGNX | D | -0.66% | |
SNDX | F | -0.66% | |
SVRA | F | -0.64% | |
OLMA | F | -0.64% | |
RGNX | D | -0.64% | |
KURA | F | -0.64% | |
CMPS | F | -0.63% | |
LQDA | F | -0.63% | |
ARWR | D | -0.61% | |
LRMR | D | -0.6% | |
AUTL | F | -0.59% | |
IDYA | F | -0.59% | |
STOK | D | -0.59% | |
RLAY | F | -0.57% | |
RXRX | D | -0.57% | |
PRTA | F | -0.57% | |
SLN | F | -0.56% | |
CLDX | D | -0.56% | |
IMTX | F | -0.55% | |
CVAC | F | -0.55% | |
CGEM | F | -0.55% | |
RCKT | F | -0.53% | |
IMNM | F | -0.53% | |
NTLA | F | -0.47% | |
ITOS | F | -0.44% | |
ARCT | F | -0.44% | |
TSHA | C | -0.43% | |
PGEN | F | -0.42% | |
EDIT | F | -0.42% | |
PRME | F | -0.37% | |
LYEL | F | -0.37% | |
FULC | F | -0.33% | |
ZNTL | D | -0.32% | |
FDMT | F | -0.31% | |
SANA | F | -0.29% | |
CABA | F | -0.21% | |
ALXO | F | -0.13% | |
HLVX | F | -0.11% | |
AVTE | C | -0.09% | |
SCLX | F | -0.09% |
OZEM: Top Represented Industries & Keywords
BBC: Top Represented Industries & Keywords